Across two large trials, roughly 20% of people treated with bepirovirsen had undetectable levels of the virus after stopping ...

Most people recover from the infection, but it poses great risks for those who don’t. A new drug may cure 1 in 5 of these ...

A new drug has cured 20% of patients with a chronic, cancer-causing disease — which was previously incurable. A viral ...

Persistent viral infections pose a unique challenge to the immune system. Prolonged antigen exposure drives T cells into a state of exhaustion — a ...

In phase III study, patients taking bulevirtide had ALT normalization and steep drops in H ...

Long-term follow up data from the Phase 1 study of pevifoscorvir sodium continues to suggest a reduction in the cccDNA reservoirData on the ...

According to the department, the Hepcludex injection is the first treatment for hepatitis delta virus (HDV) in adults lacking cirrhosis or with compensated cirrhosis. “Today’s approval fills a ...

Please provide your email address to receive an email when new articles are posted on . Having a chronic respiratory infection in addition to bronchiectasis heightened the risk for an exacerbation and ...

Combination tobevibart 300 mg + elebsiran 200 mg q4w achieved HDV RNA TND in 77% at week 72 and 88% at week 96, outperforming tobevibart monotherapy. Profound HBsAg lowering occurred with dual therapy ...

May 22 (Reuters) - Gilead Sciences said on Friday that its experimental drug for a rare and deadly liver infection that had ...

Danni-Lea Sandland and her son, Clay, developed thrush from an ultra-rare genetic disorder that impacts just a handful of ...

New research implies that a first-of-its-kind drug for hepatitis B could allow some patients to stop treatment without ...